1. "2013"
Formats
  1. Journal Article (2495)
  2. Meeting Abstract (1292)
  3. Book Section (250)
  4. Conference Paper (18)
  5. Book Whole (17)
  6. Review (1)
Groups
  1. Department of Medicine (1421)
  2. GSK Faculty (1000)
  3. Surgery (873)
  4. Solid Tumor Oncology Division (781)
  5. Survivorship Research (671)
  6. Sloan Kettering Institute Faculty (646)

More Groups

People
  1. Jose Baselga (74)
  2. Clifford Hudis (69)
  3. Jedd Wolchok (65)
  4. Howard Scher (62)
  5. Mithat Gonen (62)
  6. Ross Levine (62)

More People

Years
  1. 2013 (4073)
Publications
  1. Journal of Clinical Oncology (366)
  2. Blood (190)
  3. Cancer Research (119)
  4. International Journal of Radiation Oncology, Biology, Physics (88)
  5. Modern Pathology (88)
  6. Laboratory Investigation (81)

More Publications

Publishers
  1. Elsevier Inc. (502)
  2. American Society of Clinical Oncology (386)
  3. Springer (304)
  4. Nature Publishing Group (249)
  5. Elsevier Science, Inc. (206)
  6. American Society of Hematology (192)

More Publishers

Results (4073)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Association of mutations in chromatin modifiers with poor survival in clear cell renal cell carcinoma: Analysis of the Cancer Genome Atlas Project
    Meeting Abstract

    Hakimi, A. A.; Ostrovnaya, I.; Voss, M. H.; Motzer, R. J.; Russo, P.; Reuter, V. E.; Hsieh, J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II trial of paclitaxel, ifosfamide, and cisplatin (TIP) for previously untreated patients (pts) with intermediate- or poor-risk germ cell tumors (GCT)
    Meeting Abstract

    Feldman, D. R.; Hu, J.; Dorff, T. B.; Patil, S.; Van Alstine, L. J.; Momen, L.; Carousso, M.; Hughes, A.; Snively-Solomon, J.; Ketchens, C.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Enzalutamide in combination with docetaxel in men with prostate cancer (PC): Preliminary results from a phase I study
    Meeting Abstract

    Fleming, M. T.; Rathkopf, D. E.; Gibbons, J.; Peterson, A. C.; Hannah, A.; Forer, D.; Scher, H. I.; Morris, M. J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Long-term responders to enzalutamide (ENZA) during the phase III AFFIRM trial: Baseline characteristics and efficacy outcomes
    Meeting Abstract

    Fleming, M. T.; Scher, H. I.; Fizazi, K.; Taplin, M. E.; Forer, D.; Hirmand, M.; De Bono, J. S.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Clinical-pathologic stage discrepancy in patients with bladder cancer treated with radical cystectomy: Associations with clinical variables and survival
    Meeting Abstract

    Gray, P. J.; Fedewa, S. A.; Shipley, W. U.; Lin, C. C.; Virgo, K. S.; Kibel, A. S.; Kamat, A. M.; Rosenberg, J. E.; Jemal, A.; Zietman, A. L.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • DNA repair capacity and tumor recurrence in patients with non-muscle-invasive bladder cancer (NMIBC)
    Meeting Abstract

    Donahue, T. F.; Donat, S. M.; Patel, H.; Chou, J. F.; Bayuga, S.; Olson, S. H.; Zerillo, J. A.; Dominguez, G.; Leoce, N. M.; Herr, H. W.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Exploratory analysis of the visceral disease (VD) patient subset in COU-AA-301, a phase III study of abiraterone acetate (AA) in metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Goodman, O. B.; Flaig, T. W.; Molina, A.; Mulders, P.; Suttmann, H.; Li, J.; Kheoh, T. S.; De Bono, J. S.; Scher, H. I.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • mTOR inhibitor therapy for metastatic sarcomatoid clear cell renal cell carcinoma (ccRCC)
    Meeting Abstract

    Bastos, D. A.; Voss, M. H.; Karlo, C.; Ajeti, A.; Patil, S.; Feldman, D. R.; Molina, A. M.; Motzer, R. J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Genomic characterization of metastatic urothelial carcinoma
    Meeting Abstract

    Bambury, R. M.; Riester, M.; Bellmunt, J.; Stack, E. C.; Werner, L.; Park, R.; Iyer, G.; Loda, M.; Kantoff, P. W.; Michor, F.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Quality of life (QoL) among patients with renal cell carcinoma (RCC) treated with pazopanib versus sunitinib in the COMPARZ study
    Meeting Abstract

    Cella, D.; Hackshaw, M. D.; Diaz, J.; Huang, C.; Deen, K. C.; Crescenzo, R.; Motzer, R. J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save